��������

Lok Hang Mak currently holds the position of Associate Director at Accession Therapeutics Limited, a role commenced in July 2022. Previously, Lok Hang Mak served as Associate Director of Antibody Discovery and Engineering at Immunocore from November 2014 to August 2022, where responsibilities also included positions as Principal Scientist, Senior Scientist - Manager, and Senior Scientist. Prior experience includes a research associate role at Imperial College London from April 2009 to October 2014.